戸田正博

Masahiro Toda

所属機関・部署：

研究分野 (1件)：その他

競争的資金等の研究課題 (77件)：

全件表示

論文 (250件)：

Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology. 2024
小杉健三, 山本晃生, 松岡志保, 篠原純子, 渡邊成美, 滝沢翼, 戸田正博. telephone-induced seizureを呈した側頭葉てんかんの一例. 臨床神経生理学. 2023. 51. 5. 565-565
Toshiki Tezuka, Tomonori Nukariya, Masahiro Katsumata, Tsubasa Miyauchi, Daiki Tokuyasu, Shunpei Azami, Yoshikane Izawa, Narihito Nagoshi, Hirokazu Fujiwara, Katsuhiro Mizutani, et al. "Missing-piece" sign with dural arteriovenous fistula at craniocervical junction: A case report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2023. 32. 7. 107152-107152
Yohei Kitamura, Masahiro Toda. [Medical Treatments for Malignant Brain Tumor]. Brain and nerve = Shinkei kenkyu no shinpo. 2023. 75. 5. 561-566
Naoki Oishi, Masaru Noguchi, Masato Fujioka, Kiyomitsu Nara, Koichiro Wasano, Hideki Mutai, Rie Kawakita, Ryota Tamura, Kosuke Karatsu, Yukina Morimoto, et al. Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis. Scientific reports. 2023. 13. 1. 6595-6595

MISC (68件)：

戸田正博, 田村亮太, 吉田一成. 三叉神経鞘腫の手術-三叉神経の温存ー. 脳神経外科ジャーナル Vol.31 Supplement2. 2022. 31. 81-87
戸田正博, 吉田一成. Subtemporal Approach: Intra-and Extradual Approach,Anterior Petrosal Approach, and Endonasal Approach. 脳神経外科ジャーナル Vol.31 Supplement 2. 2022. 30-39
Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M. Recent progress in the research of suicide gene therapy for malignant glioma. Neurosurgical Review. 2021. 44. 1. 29-49
田村亮太, 楊正博, 三好浩之, オルテアサンペトラ, 佐谷秀行, 岡野栄之, 戸田正博. ゲノム編集iPS細胞を用いた悪性神経膠腫に対する革新的遺伝子細胞療法の開発. 日本脳腫瘍学会プログラム・抄録集. 2021. 39th
Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, et al. Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 (Nature Communications, (2019), 10, 1, (5758), 10.1038/s41467-019-13640-1). Nature Communications. 2020. 11. 1

特許 (20件)：

書籍 (6件)：

Stem cell research for the treatment of malignant glioma.
Brain Tumor, InTech, Croatia 2017
Glioma Antigen Glioma: Immunotherapeutic approaches
R Yamanaka (Ed.), In Landes Bioscience 2012 ISBN:9781461431459
Brain tumor stem cells and anti-angiogenetic therapy
Cancer Stem Cells, The Cutting Edge Stanley Shostak (Ed.), InTech, Croatia 2011 ISBN:9789533075808
Immunotherapy targeted at brain cancer stem cells
Brain Tumor Immunotherapy, The Open Cancer Immunology Journal Terry Lichtor (Ed.), Bentham open, 2010
Treatment of metastatic brain tumors with a replication-competent multi-mutated herpes simplex virus-1.
Neural Development, Springer-Verlag 1999

講演・口頭発表等 (595件)：

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

戸田 正博